Endra Life Sciences Inc (NDRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 11,278 | 7,127 | 9,462 | 11,793 | 14,043 |
| Inventories | 2,375 | 1,930 | 1,285 | 1,500 | 1,325 |
| Other current assets | 0 | 0 | 0 | 0 | 6 |
| TOTAL | $14,488 | $10,119 | $12,094 | $14,470 | $16,343 |
| Non-Current Assets | |||||
| PPE Net | 240 | 201 | 131 | 162 | 192 |
| Other Non-Current Assets | 582 | 616 | 649 | 682 | 708 |
| TOTAL | $822 | $818 | $781 | $844 | $900 |
| Total Assets | $15,309 | $10,937 | $12,875 | $15,314 | $17,243 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,360 | 1,221 | 1,411 | 1,449 | 1,515 |
| TOTAL | $1,502 | $1,358 | $1,544 | $1,577 | $1,638 |
| Non-Current Liabilities | |||||
| Long Term Debt | 29 | 29 | 29 | 29 | 29 |
| Other Non-Current Liabilities | 444 | 482 | 518 | 553 | 586 |
| TOTAL | $473 | $510 | $547 | $581 | $615 |
| Total Liabilities | $1,975 | $1,868 | $2,090 | $2,158 | $2,253 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 2 | 2 | 1 | 1 | 1 |
| Common Shares | 6 | 5 | 0 | 4 | 4 |
| Retained earnings | -75,140 | -71,549 | -68,691 | -65,586 | -62,928 |
| Other shareholders' equity | 6 | 9 | 14 | 43 | 75 |
| TOTAL | $13,334 | $9,069 | $10,784 | $13,156 | $14,990 |
| Total Liabilities And Equity | $15,309 | $10,937 | $12,875 | $15,314 | $17,243 |